Radiation Dose Constraints for the Heart
The most critical heart dose constraint is V25Gy <10% (less than 10% of the whole heart volume receiving 25 Gy in 2 Gy fractions), which is associated with only 1-2% probability of cardiac mortality within 15 years after radiotherapy. 1
General Heart Tolerance Doses
- Radiation tolerance doses for late cardiac effects are estimated between 30-40 Gy 2, 1, 2, 1
- Permanent cardiac complications occur less frequently under a total dose of 40 Gy, though treatment should not be systematically limited if inadequate for disease control 1, 2
- Patients with mediastinal/heart doses >30 Gy are at high risk for RT-induced complications and require close follow-up 1
Specific Dose Constraints by Clinical Context
For Breast Cancer Radiotherapy
Mean heart dose should be kept <2.5 Gy 3
Additional breast cancer-specific constraints include:
- Mean left ventricle dose <3 Gy 3
- V5 left ventricle <17% 3
- V23 left ventricle <5% 3
- Mean LAD (left anterior descending artery) dose <10 Gy 3
- V30 LAD <2% 3
- V40 LAD <1% 3
For Lung Cancer Radiotherapy (Reirradiation)
Composite dose constraints (in 2 Gy equivalents): 4
For non-small cell lung cancer, a maximum dose to the combined cardiac region (right atrium, right coronary artery, ascending aorta) should not exceed 23 Gy (EQD2) 5
Risk Factors That Lower Tolerance
Cardiac radiation tolerance is significantly reduced by: 1
- Dose per fraction >2 Gy 1
- Large volume of irradiated heart 1
- Younger age at exposure 1
- Concurrent cytotoxic chemotherapy, endocrine therapy, or trastuzumab 1
- Cardiovascular risk factors (diabetes, hypertension, dyslipidemia, obesity, smoking) 1, 6
Cardiac Structures Affected and Timing
Different cardiac structures demonstrate varying radiation sensitivities: 2, 1, 2, 1
- Coronary arteries: Premature atherosclerosis appears 10-15 years post-RT, primarily affecting LAD and right coronary artery 2, 1, 2, 1
- Pericardium: Acute/chronic pericarditis appears 6-12 months following RT 2, 1, 2, 1
- Myocardium: Diffuse interstitial fibrosis leading to congestive heart failure 2, 1, 2, 1
- Valves: Stenosis/regurgitation (mainly mitral and aortic) 2, 1, 2, 1
- Conduction system: Heart block and arrhythmias 2, 1, 2, 1
Techniques to Minimize Cardiac Dose
Modern RT techniques significantly reduce cardiac exposure: 1, 2, 1, 2, 1
- Use 3D treatment planning with dose-volume histogram for accurate heart dose calculation 1, 2, 1, 2, 1
- Linear accelerator photons with multiple-field conformal or IMRT are preferred over older techniques 1, 2, 1, 2, 1
- For breast/chest wall RT: Use 6 MV photons with cardiac-sparing lead blocks 1, 2, 1, 2, 1
- Four-field IMRT offers better cardiac sparing than partial shielding 1, 2, 1, 2
- Proton therapy delivers the lowest cardiac doses (mean 0.5-2.6 Gy depending on target) 7
- For mediastinal RT: Use equal weighting of anterior/posterior portals, subcarinal block after 30 Gy, and shrinking-field technique 1, 2
Common Pitfalls
- Do not rely solely on mean heart dose—cardiac substructure doses (particularly left ventricle and LAD) are critical for risk assessment 3, 5, 8
- Maximum heart distance (MHD) correlates with mean heart dose: Every 1-cm increase in MHD increases mean heart dose by 2.9% 1, 2, 1, 2, 1
- Cardiovascular risk begins within the first 5 years after RT and continues for decades—long-term surveillance is essential 6
- Even doses below traditional thresholds carry risk—there is no completely safe dose, and risk increases linearly with dose 6, 7